Position in PCVX
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$22,187,407
-$3,724,016 QoQ
Shares Held
381,686
-14.4% QoQ
Ownership
0.257%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#54
of 329 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PCVX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Ensign Peak Advisors, Inc holds $1,111,483,806 across 123 Biotechnology names. PCVX ranks #16 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
210,483 | $104,553,220 | |
| 2 | INSM |
INSMED Inc
|
702,951 | $74,948,635 | |
| 3 | ABVX |
Abivax S.A.
|
504,471 | $67,225,805 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
760,977 | $56,677,566 | |
| 5 | ARGX |
Argenx SE
|
52,027 | $48,269,089 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
508,056 | $41,442,127 | |
| 7 | TVTX |
Travere Therapeutics, Inc.
|
591,815 | $33,621,010 | |
| 8 | SRRK |
Scholar Rock Holding Corp
|
579,052 | $31,847,860 |
All Filings in PCVX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,187,407 | 381,686 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $25,911,423 | 445,903 | Shares | Sole | 2026-08-18 | |
| 2025-12-31 | $24,347,524 | 527,688 | Shares | Sole | 2026-08-18 | |
| 2025-09-30 | $19,049,285 | 528,853 | Shares | Sole | 2026-08-18 | |
| 2025-06-30 | $17,301,919 | 532,203 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $28,099,481 | 744,160 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $47,980,438 | 586,128 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $62,486,835 | 546,835 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $34,937,117 | 462,682 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $32,495,067 | 475,700 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $22,679,026 | 361,131 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $14,059,570 | 275,786 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $13,772,752 | 275,786 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $9,328,247 | 248,886 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $11,917,301 | 248,536 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $2,485,800 | 103,575 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $1,630,041 | 74,910 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $866,985 | 35,900 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $33,781 | 1,420 | Shares | Sole | 2022-02-11 | |
| 2021-03-31 | $412,241 | 20,873 | Shares | Sole | 2021-05-12 | |
| 2020-12-31 | $554,595 | 20,873 | Shares | Sole | 2021-02-12 | |
| No filing history on record for this holder in this stock. | ||||||